Extraction form for project: IPMP (Integrated Pain Management Programs)

Design Details

1. What type of program does the study assess (IPMP or CPMP)?
Integrated Pain Management Program (IPMP): Based in, integrated with, coordinated by primary care. Comprehensive Pain Management Program (CPMP): Referral based and separate from primary care.
2. In what country was the study conducted?
List all applicable countries.
3. What study design was used?
Please select the appropriate study design for the study. If the study design is not listed, you may add the appropriate study design.
4. Mean age
Report across all patients included in relevant study arms. Round to whole number. Include the word "years" after reporting the mean age.
5. % male
Report across all patients included in relevant study arms. Round to whole number. Include "%" symbol.
6. % Non-white
Report across all patients included in relevant study arms. Round to whole number. Include "%" symbol. If not reported, put NR.
7. Mean duration of pain or symptoms
Report across all patients included in relevant study arms. Round to whole number. Report duration in terms of months. If not reported, put NR.
8. Pain etiology/type
9. Disability
Disability can be measured in several ways. For example, authors may report the percent of patients receiving disability payments or they may report the mean score of a continuous disability scale such as the Pain Disability Index. Either are appropriate here, just be explicit about what is being reported.
10. Comorbidities
Extract the percent of patients with relevant comorbidities. Round percentages to whole numbers. If not reported, put NR.
% Depression diagnosis
% Anxiety diagnosis
% PTSD disagnosis
% Overweight or obese
% w/ Substance Use Disorder
% Smokers
% Suicidal
11. Randomized, Analyzed, and Attrition (at longest followup point)
For attrition report as: % (n/N)
Randomized
Analyzed
Attrition
12. How was the study funded?
13. Notes and comments

Arms

Arm NameArm Description
CPMPNR
Pharmacologic therapy + physiokinesiotherapyReceived the medication and phi-kinesiotherapy components of the full intervention (Group A)
Pharmacologic therapy onlyReceived only the medication component of the intervention (Group A)

Arm Details

1. Is the program practice-based or system-based?
CPMP
Pharmacologic therapy + physiokinesiotherapy
Pharmacologic therapy only
2. How many patients were randomized to this treatment arm?
CPMP
Pharmacologic therapy + physiokinesiotherapy
Pharmacologic therapy only
3. Program duration (weeks)
Please report the duration of the program in weeks and include "weeks" in the text box.
CPMP
Pharmacologic therapy + physiokinesiotherapy
Pharmacologic therapy only
4. Number of sessions per week
Report as X sessions/week
CPMP
Pharmacologic therapy + physiokinesiotherapy
Pharmacologic therapy only
5. Was the program conducted in the inpatient or outpatient setting?
Select one.
CPMP
Pharmacologic therapy + physiokinesiotherapy
Pharmacologic therapy only
6. Physical Functioning/Reconditioning & Psychological and Mental Health Components of Intervention
For treatment providers, you may write-in any options that are needed that are not already presented. For duration of treatment report as "X sessions per week over X weeks", when possible. For anything not reported, put NR.
CPMP
Physical Functioning/Reconditioning Components of InterventionPsychological and Mental Health Components of Intervention
Treatment types
Treatment providers
Mode of delivery
Duration of treatment
Tailoring
Adherence
Pharmacologic therapy + physiokinesiotherapy
Physical Functioning/Reconditioning Components of InterventionPsychological and Mental Health Components of Intervention
Treatment types
Treatment providers
Mode of delivery
Duration of treatment
Tailoring
Adherence
Pharmacologic therapy only
Physical Functioning/Reconditioning Components of InterventionPsychological and Mental Health Components of Intervention
Treatment types
Treatment providers
Mode of delivery
Duration of treatment
Tailoring
Adherence
7. Medication Review and/or Management Components of Intervention
CPMP
Pharmacologic therapy + physiokinesiotherapy
Pharmacologic therapy only
8. Additional components of the intervention
CPMP
Pharmacologic therapy + physiokinesiotherapy
Pharmacologic therapy only
9. Description of care coordination/collaboration
CPMP
Pharmacologic therapy + physiokinesiotherapy
Pharmacologic therapy only

Sample Characteristics

N/A

Outcomes

TypeDomainSpecific measurement (i.e., tool/definition/specific outcome)PopulationsTimepoints
ContinuousPainVisual Analogue Scale - All patients
  • All Participants
  • Baseline
  • Immediately Post-intervention
ContinuousPainVisual Analogue Scale - Non-clinical catastrophizers
  • All Participants
  • Baseline
  • Immediately Post-intervention
ContinuousPainVisual Analogue Scale - Clinical catastrophizers
  • All Participants
  • Baseline
  • Immediately Post-intervention
ContinuousFunctionRoland-Morris Disability Questionnaire - All patients
  • All Participants
  • Baseline
  • Immediately Post-intervention
ContinuousQOLProfile of Mood States Short Version - Emotional Distress
  • All Participants
  • Baseline
  • Immediately Post-intervention
ContinuousQOLPain Catastrophizing Scale - Non-clinical catastrophizers
  • All Participants
  • Baseline
  • Immediately Post-intervention
ContinuousQOLPain Catastrophizing Scale - Clinical catastrophizers
  • All Participants
  • Baseline
  • Immediately Post-intervention

Outcome Details

N/A

Risk of Bias Assessment

1. Randomization adequate?
Rating
2. Allocation concealment adequate?
Rating
3. Groups similar at baseline?
Rating
4. Outcome assessors masked?
Rating
5. Care providers masked?
Rating
6. Patient masked?
Rating
7. Reporting of attrition, crossovers, adherence, and contamination?
Rating
8. Loss to followup acceptable?
Overall ≤20%?
Difference between groups <10%?
9. Intention-to-treat (ITT) analysis?
Overall ≤20%?
10. Outcomes prespecified?
Overall ≤20%?
11. Quality determination
Overall ≤20%?

Results

Continuous


Pain (Visual Analogue Scale - All patients)

All Participants
Descriptive StatisticsBetween Arm Comparisons
CPMPPharmacologic therapy + physiokinesiotherapyPharmacologic therapy only
Baseline
Total (N analyzed)
Mean Difference (MD)
Mean
95% CI low (MD)
SD
95% CI high (MD)
SD
SD (MD)
p value (MD)
Immediately Post-intervention
Total (N analyzed)
Mean Difference (MD)
Mean
95% CI low (MD)
SD
95% CI high (MD)
SD
SD (MD)
p value (MD)
Within Arm ComparisonsNet Comparisons
CPMPPharmacologic therapy + physiokinesiotherapyPharmacologic therapy only

Pain (Visual Analogue Scale - Non-clinical catastrophizers)

All Participants
Descriptive StatisticsBetween Arm Comparisons
CPMPPharmacologic therapy + physiokinesiotherapyPharmacologic therapy only
Baseline
Total (N analyzed)
Mean Difference (MD)
Mean
95% CI low (MD)
SD
95% CI high (MD)
SD
SD (MD)
p value (MD)
Immediately Post-intervention
Total (N analyzed)
Mean Difference (MD)
Mean
95% CI low (MD)
SD
95% CI high (MD)
SD
SD (MD)
p value (MD)
Within Arm ComparisonsNet Comparisons
CPMPPharmacologic therapy + physiokinesiotherapyPharmacologic therapy only

Pain (Visual Analogue Scale - Clinical catastrophizers)

All Participants
Descriptive StatisticsBetween Arm Comparisons
CPMPPharmacologic therapy + physiokinesiotherapyPharmacologic therapy only
Baseline
Total (N analyzed)
Mean Difference (MD)
Mean
95% CI low (MD)
SD
95% CI high (MD)
SD
SD (MD)
p value (MD)
Immediately Post-intervention
Total (N analyzed)
Mean Difference (MD)
Mean
95% CI low (MD)
SD
95% CI high (MD)
SD
SD (MD)
p value (MD)
Within Arm ComparisonsNet Comparisons
CPMPPharmacologic therapy + physiokinesiotherapyPharmacologic therapy only

Function (Roland-Morris Disability Questionnaire - All patients)

All Participants
Descriptive StatisticsBetween Arm Comparisons
CPMPPharmacologic therapy + physiokinesiotherapyPharmacologic therapy only
Baseline
Total (N analyzed)
Mean Difference (MD)
Mean
95% CI low (MD)
SD
95% CI high (MD)
SD
SD (MD)
p value (MD)
Immediately Post-intervention
Total (N analyzed)
Mean Difference (MD)
Mean
95% CI low (MD)
SD
95% CI high (MD)
SD
SD (MD)
p value (MD)
Within Arm ComparisonsNet Comparisons
CPMPPharmacologic therapy + physiokinesiotherapyPharmacologic therapy only

QOL (Profile of Mood States Short Version - Emotional Distress)

All Participants
Descriptive StatisticsBetween Arm Comparisons
CPMPPharmacologic therapy + physiokinesiotherapyPharmacologic therapy only
Baseline
Total (N analyzed)
Mean Difference (MD)
Mean
95% CI low (MD)
SD
95% CI high (MD)
SD
SD (MD)
p value (MD)
Immediately Post-intervention
Total (N analyzed)
Mean Difference (MD)
Mean
95% CI low (MD)
SD
95% CI high (MD)
SD
SD (MD)
p value (MD)
Within Arm ComparisonsNet Comparisons
CPMPPharmacologic therapy + physiokinesiotherapyPharmacologic therapy only

QOL (Pain Catastrophizing Scale - Non-clinical catastrophizers)

All Participants
Descriptive StatisticsBetween Arm Comparisons
CPMPPharmacologic therapy + physiokinesiotherapyPharmacologic therapy only
Baseline
Total (N analyzed)
Mean Difference (MD)
Mean
95% CI low (MD)
SD
95% CI high (MD)
SD
SD (MD)
p value (MD)
Immediately Post-intervention
Total (N analyzed)
Mean Difference (MD)
Mean
95% CI low (MD)
SD
95% CI high (MD)
SD
SD (MD)
p value (MD)
Within Arm ComparisonsNet Comparisons
CPMPPharmacologic therapy + physiokinesiotherapyPharmacologic therapy only

QOL (Pain Catastrophizing Scale - Clinical catastrophizers)

All Participants
Descriptive StatisticsBetween Arm Comparisons
CPMPPharmacologic therapy + physiokinesiotherapyPharmacologic therapy only
Baseline
Total (N analyzed)
Mean Difference (MD)
Mean
95% CI low (MD)
SD
95% CI high (MD)
SD
SD (MD)
p value (MD)
Immediately Post-intervention
Total (N analyzed)
Mean Difference (MD)
Mean
95% CI low (MD)
SD
95% CI high (MD)
SD
SD (MD)
p value (MD)
Within Arm ComparisonsNet Comparisons
CPMPPharmacologic therapy + physiokinesiotherapyPharmacologic therapy only